Skip to main content
. 2020 Apr 8;7:16. doi: 10.3389/fsurg.2020.00016

Table 1.

Summary of demographic and procedural data.

Variable Patients who survived (n = 69) Patients who died (n = 42) P-value
Age (years) 60.4 ± 17.3 66.6 ± 18.3 0.076
Sex, male 30 (43.5%) 14 (33.3%) 0.289
NIHSS score 14.9 ± 7.1 19.6 ± 8.3 0.002
Transferred from an outside hospital 38 (55.1%) 24 (57.1%) 0.831
Number of co-morbidities 2.3 ± 1.7 2.5 ± 1.5 0.689
Hypertension 43 (62.3%) 29 (69.0%) 0.471
CAD 17 (24.6%) 9 (21.4%) 0.699
DM 20 (29.0%) 12 (28.6%) 0.963
HLD 37 (53.6%) 18 (42.9%) 0.271
Afib 20 (29.0%) 8 (19.0%) 0.242
History of cancer 3 (4.4%) 11 (26.2%) 0.002
Hx of prior DVT 2 (2.9%) 6 (14.3%) 0.056
Hx of prior stroke 20 (29.0%) 11 (26.2%) 0.753
New STEMI during admission 4 (5.8%) 7 (16.7%) 0.098
Time to revascularization (min) 348.4 ± 270.7 398.6 ± 295.0 0.560
Procedure length (min) 73.2 ± 38.3 87.1 ± 46.4 0.120
Hemorrhagic conversion 15 (21.7%) 20 (47.6%) 0.004
Procedural complications 5 (7.4%) 11 (26.2%) 0.011
TICI 2b or 3 revascularization 54 (78.3%) 21 (50.0%) 0.003
Treated with tPA and thrombectomy 46 (66.7%) 29 (69.0%) 0.797
Decompressive hemicraniotomy 4 (5.80%) 1(2.38%) 0.648
Location of stroke, posterior 10 (14.5%) 9 (21.4%) 0.347

Data are reported as mean ± standard deviation or total (%) as appropriate.

Boldface values are statistically significant at p < 0.05.

NIHSS, National Institutes of Health Stroke Scale; CAD, coronary artery disease; DM, diabetes mellitus, HLD, hyperlipidemia; Afib, atrial fibrillation; DVT, deep vein thrombosis; STEMI, ST-elevation myocardial infarction; TICI, thrombolysis in cerebral infarction; tPA, tissue plasminogen activator.